Its especially common for people on weight-loss medications, since they reach their goal weight and assume they can keep it off themselves
Downstream interaction by glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide agonism is required for synergistic effects on body weight
Rahman adds, Obesity and overweight are highly prevalent conditions associated with considerable morbidity and mortality, and successful weight loss interventions can lead to important reductions in cardiometabolic risk. Though semaglutide can lead to meaningful weight loss in some individuals, it comes with important risks and limitations
completely excluded patients with obesity [1, 2]
Benefits: Helps reduce fatigue Improves hair, skin, and nail health Supports a healthy nervous system Reduces stress and boosts mood 3
Victoza is a once-daily GLP-1 RA therapy for patients with type 2 diabetes Indicated as an adjunct to diet and exercise to improve glycemic control in adults and pediatric patients aged 10 years and older with type 2 diabetes and to reduce the risk of major adverse cardiovascular events (cardiovascular death, non-fatal myocardial infarction, or non-fatal stroke) in adults with type 2 diabetes and established cardiovascular disease